| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.05 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.05 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.058 | 0.05 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |